Rob Davis

Companies

• Merck & Co.Chair Apr 28, 2023 to now¹⁰
• Merck & Co.Board member Jul 1, 2021 to now¹¹
• Merck & Co.Chief executive officer Jul 1, 2021 to now¹¹
• Duke EnergyBoard member Jan 9, 2018 to now¹²
• Merck & Co.President May 6, 2021 to Jul 26, 2022¹³
• Merck & Co.Chief financial officer May 12, 2016 to Mar 2, 2021¹⁴
• Merck & Co.Exec V-P & Chief Fince Officer Apr 29, 2014 to May 5, 2015¹⁵
• Baxter InternationalCorporate Vice President May 18, 2007 to Mar 6, 2014¹⁶
• Baxter InternationalChief financial officer May 18, 2006 to Mar 17, 2010¹⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Merck & Co. MRK450,351 shares¹⁸$65.7M at $145.87May 7, 2026
• Baxter International BAX128,146 shares¹⁹$3.2M at $25.25Jan 29, 2014
• Duke Energy DUK14,262 shares²⁰$1.7M at $121.47May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 7, 2026Granted 1,602 shares at $124.87 of Duke Energy²⁰
• Apr 29, 2026Shares withheld for tax 6,551 shares at $110.03 of Merck & Co.²¹
• Apr 29, 2026Exercised options 13,300 shares at $110.03 of Merck & Co.²¹
• Feb 4, 2026Sold 32,462 shares at $118.35 of Merck & Co.²²
• Feb 4, 2026Sold 14,972 shares at $117.38 of Merck & Co.²²
• Jan 26, 2026Granted 47,434 shares at $107.40 of Merck & Co.²³
• May 1, 2025Granted 1,607 shares at $121.33 of Duke Energy²⁴
• Jan 27, 2025Granted 95,275 shares at $97.94 of Merck & Co.²⁵
• May 9, 2024Granted 1,699 shares at $103.02 of Duke Energy²⁶
• Feb 14, 2024Sold 85,021 shares at $125.40 of Merck & Co.²⁷
• Feb 14, 2024Exercised options 85,021 shares at $73.73 of Merck & Co.²⁷
• Feb 13, 2024Sold 25,324 shares at $126.37 of Merck & Co.²⁷
• Feb 13, 2024Sold 124,676 shares at $125.74 of Merck & Co.²⁷
• Feb 13, 2024Exercised options 108,491 shares at $73.73 of Merck & Co.²⁷
• Feb 13, 2024Exercised options 41,509 shares at $75.36 of Merck & Co.²⁷
• Jan 22, 2024Granted 76,510 shares at $119.43 of Merck & Co.²⁸
• May 4, 2023Granted 1,784 shares at $98.11 of Duke Energy²⁹
• Apr 28, 2023Sold 143,329 shares at $114.93 of Merck & Co.³⁰
• Apr 28, 2023Exercised options 143,329 shares at $56.04 of Merck & Co.³⁰
• Jan 23, 2023Granted 24,224 shares at $109.88 of Merck & Co.³¹
• Nov 9, 2022Sold 100 shares at $103.59 of Merck & Co.³²
• Nov 9, 2022Sold 79,918 shares at $102.98 of Merck & Co.³²
• Nov 9, 2022Sold 87,595 shares at $101.94 of Merck & Co.³²
• Nov 9, 2022Exercised options 167,613 shares of Merck & Co.³²
• May 5, 2022Granted 1,590 shares at $110.05 of Duke Energy³³

In the news

2 recent articles from 1 outlet we read name Rob Davis. We match the full name, and check the article also names one of their companies or that they are well known.

• Wall Street's latest AI spook, Netflix layoffs, 'good debt' and more in Morning SquawkCNBC, center, Oct 15, 2026…question for college students and their parents, as the perceived benefits of higher education shift. Merck CEO Rob Davis told CNBC's Annika Kim Constantino yesterday that he expects manufacturing of the company's breakthrough cancer vaccin…
• Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeCNBC, center, Oct 14, 2026…Merck CEO Rob Davis told CNBC on Wednesday that he expects the company's breakthrough cancer vaccine with Moderna to get faster to manufacture over time. Shortening the current six-week timeline could potentially help the companies reach mo…